Research field (4)：
Hematology and oncology
, Infectious disease
, Allergies and connective tissue disease
, Dermatology
Research theme for competitive and other funds (2)：
2022 - 2025 慢性皮膚炎症と精子形成不全・動脈硬化症・認知症等内臓病変とのクロストーク
2004 - 2005 表皮におけるバニロイド受容体ファミリーの機能解析
Papers (52)：
Shohei Iida, Hirotaka Shoji, Fumihiro Kawakita, Takehisa Nakanishi, Yoshiaki Matsushima, Makoto Kondo, Koji Habe, Hidenori Suzuki, Tsuyoshi Miyakawa, Keiichi Yamanaka. Inflammatory Skin Disease Causes Anxiety Symptoms Leading to an Irreversible Course. International journal of molecular sciences. 2023. 24. 6
Hiroyuki Goto, Makoto Kondo, Shohei Iida, Yoshiaki Matsushima, Yasuo Nakai, Masanao Naka, Koji Habe, Masami Nishii, Keiichi Yamanaka. Psoriasis-like skin lesions occurring at remote sites after topical imiquimod. The Journal of dermatology. 2022. 49. 10. e395-e396
Yoshiaki Matsushima, Kento Mizutani, Shohei Iida, Masako Ichishi, Takehisa Nakanishi, Karin Okada, Ai Umaoka, Makoto Kondo, Koji Habe, Masatoshi Watanabe, et al. Severe skin inflammation leads to salivary gland atrophy and dysfunction. The Journal of dermatology. 2022. 49. 6. 642-647
Shohei Iida, Takehisa Nakanishi, Fumiyasu Momose, Masako Ichishi, Kento Mizutani, Yoshiaki Matsushima, Ai Umaoka, Makoto Kondo, Koji Habe, Yoshifumi Hirokawa, et al. IL-17A Is the Critical Cytokine for Liver and Spleen Amyloidosis in Inflammatory Skin Disease. International Journal of Molecular Sciences. 2022. 23. 10. 5726-5726
Takehisa Nakanishi, Kento Mizutani, Shohei Iida, Yoshiaki Matsushima, Ai Umaoka, Makoto Kondo, Koji Habe, Keiichi Yamanaka. Janus Kinase Inhibitors Ameliorated Gastrointestinal Amyloidosis and Hypoalbuminemia in Persistent Dermatitis Mouse Model. International journal of molecular sciences. 2021. 23. 1
K. Mizutani, Y. Matsushima, K. Okada, A. Yamagiwa, T. Akeda, M. Kondo, M. Kakeda, K. Habe, K. Yamanaka. Is neutrophil the dominant IL-17 producer in psoriasis?. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2017. 137. 10. S257-S257
A case of Merkel cell carcinoma with distal metastasis treated without impairing the patient's QOL for nearly two years. 2017. 71. 8. 611-615
